Curative effect of 6-mercaptopurine in patients with chronic liver disease
β Scribed by Wada, M. ;Yamamoto, S. ;Fukae, K. ;Maruyama, T. ;Monna, T.
- Publisher
- Springer-Verlag
- Year
- 1967
- Tongue
- English
- Weight
- 64 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
with consequent organ dysfunction. Carnitine metabolism Carnitine metabolism was studied in 79 patients with could be disturbed by a variety of mechanisms in patients chronic liver disease, including 22 patients with noncirwith chronic liver disease. Dietary intake of carnitine could rhotic liver di
The pharmacokinetics of the dihydropyridine calcium antagonist isradipine has been examined in 8 healthy volunteers, 7 patients with non-cirrhotic chronic liver disease (CLD), and 8 patients with biopsy-proven cirrhosis (CIR). Isradipine was simultaneously given orally (12C 5 mg) and i.v. (13C 1 mg)
## Abstract Patients with autoimmune chronic active hepatitis (AICAH) and certain other chronic liver disorders often have very high titres of haemagglutination βinhibition (HI) antibodies to rubella virus. In this study it is shown, using floatation centrifugation, that the high rubella HI reactiv